|
1
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singh S, Singh PP, Roberts LR and Sanchez
W: Chemopreventive strategies in hepatocellular carcinoma. Nat Rev
Gastroenterol Hepatol. 11:45–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng JW and Lv Y: New progress of
non-surgical treatments for hepatocellular carcinoma. Med Oncol.
30:3812013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: an update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bravi F, Bosetti C, Tavani A, Gallus S and
La Vecchia C: Coffee reduces risk for hepatocellular carcinoma: an
updated meta-analysis. Clin Gastroenterol Hepatol. 11:1143–1421.
2013. View Article : Google Scholar
|
|
6
|
Calvisi DF, Ladu S, Hironaka K, Factor VM
and Thorgeirsson SS: Vitamin E down-modulates iNOS and NADPH
oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer.
J Hepatol. 41:815–822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sawada N, Inoue M, Iwasaki M, et al:
Consumption of n-3 fatty acids and fish reduces risk of
hepatocellular carcinoma. Gastroenterology. 142:1468–1475. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hursting SD, Thornquist M and Henderson
MM: Types of dietary fat and the incidence of cancer at five sites.
Prev Med. 19:242–253. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu K, Stamler J, Moss D, Garside D,
Persky V and Soltero I: Dietary cholesterol, fat, and fibre, and
colon-cancer mortality. An analysis of international data. Lancet.
2:782–785. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferro-Luzzi A and Sette S: The
Mediterranean Diet: an attempt to define its present and past
composition. Eur J Clin Nutr. 43(Suppl 2): 13–29. 1989.PubMed/NCBI
|
|
11
|
Andreadou I, Mikros E, Ioannidis K, et al:
Oleuropein prevents doxorubicin-induced cardiomyopathy interfering
with signaling molecules and cardiomyocyte metabolism. J Mol Cell
Cardiol. 69:4–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hassan ZK, Elamin MH, Omer SA, et al:
Oleuropein induces apoptosis via the p53 pathway in breast cancer
cells. Asian Pac J Cancer Prev. 14:6739–6742. 2013. View Article : Google Scholar
|
|
13
|
Bulotta S, Corradino R, Celano M, et al:
Antioxidant and antigrowth action of peracetylated oleuropein in
thyroid cancer cells. J Mol Endocrinol. 51:181–189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cardeno A, Sánchez-Hidalgo M, Rosillo MA
and Alarcón de la Lastra C: Oleuropein, a secoiridoid derived from
olive tree, inhibits the proliferation of human colorectal cancer
cell through downregulation of HIF-1α. Nutr Cancer. 65:147–156.
2013. View Article : Google Scholar
|
|
15
|
Cotter TG: Apoptosis and cancer: the
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: a link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kumar A, Rajendran V, Sethumadhavan R and
Purohit R: AKT kinase pathway: a leading target in cancer research.
Scientific World Journal. 2013:7561342013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pavlidou A and Vlahos NF: Molecular
alterations of PI3K/Akt/mTOR pathway: a therapeutic target in
endometrial cancer. Scientific World Journal. 2014:7097362014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Franke TF, Hornik CP, Segev L, Shostak GA
and Sugimoto C: PI3K/Akt and apoptosis: size matters. Oncogene.
22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Datta SR, Dudek H, Tao X, et al: Akt
phosphorylation of BAD couples survival signals to the
cell-intrinsic death machinery. Cell. 91:231–241. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hahn-Windgassen A, Nogueira V, Chen CC,
Skeen JE, Sonenberg N and Hay N: Akt activates the mammalian target
of rapamycin by regulating cellular ATP level and AMPK activity. J
Biol Chem. 280:32081–32089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rokutanda S, Fujita T, Kanatani N, et al:
Akt regulates skeletal development through GSK3, mTOR, and FoxOs.
Dev Biol. 328:78–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adams JM and Cory S: Life-or-death
decisions by the Bcl-2 protein family. Trends Biochem Sci.
26:61–66. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signalling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vlahos CJ, Matter WF, Hui KY and Brown RF:
A specific inhibitor of phosphatidylinositol 3-kinase,
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one(LY294002). J Biol
Chem. 269:5241–5248. 1994.PubMed/NCBI
|
|
26
|
Nogueira V, Park Y, Chen CC, et al: Akt
determines replicative senescence and oxidative or oncogenic
premature senescence and sensitizes cells to oxidative apoptosis.
Cancer Cell. 14:458–470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Robey RB and Hay N: Is Akt the ‘Warburg
kinase’? - Akt-energy metabolism interactions and oncogenesis.
Semin Cancer Biol. 19:25–31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fini L, Hotchkiss E, Fogliano V, et al:
Chemopreventive properties of pinoresinol-rich olive oil involve a
selective activation of the ATM-p53 cascade in colon cancer cell
lines. Carcinogenesis. 29:139–146. 2008. View Article : Google Scholar
|
|
29
|
La Vecchia C: Association between
Mediterranean dietary patterns and cancer risk. Nutr Rev. 67(Suppl
1): S126–S129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Menendez JA, Papadimitropoulou A, Vellon L
and Lupu R: A genomic explanation connecting ‘Mediterranean diet’,
olive oil and cancer: oleic acid, the main monounsaturated fatty
acid of olive oil, induces formation of inhibitory ‘PEA3
transcription factor-PEA3 DNA binding site’ complexes at the
Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach
cancer cells. Eur J Cancer. 42:2425–2432. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaufmann SH and Earnshaw WC: Induction of
apoptosis by cancer chemotherapy. Exp Cell Res. 256:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wiita AP, Ziv E, Wiita PJ, et al: Global
cellular response to chemotherapy-induced apoptosis. Elife.
29:e012362013.
|
|
33
|
Czerski L and Nunez G: Apoptosome
formation and caspase activation: is it different in the heart? J
Mol Cell Cardiol. 37:643–652. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fulda S and Debatin KM: Apoptosis
signaling in tumor therapy. Ann NY Acad Sci. 1028:150–156. 2004.
View Article : Google Scholar
|
|
35
|
Zhang L, Yu J, Park BH, Kinzler KW and
Vogelstein B: Role of BAX in the apoptotic response to anticancer
agents. Science. 290:989–992. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Minguez B, Tovar V, Chiang D, Villanueva A
and Llovet JM: Pathogenesis of hepatocellular carcinoma and
molecular therapies. Curr Opin Gastroenterol. 25:186–194. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Saxena NK, Sharma D, Ding X, et al:
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling
is involved in leptin-mediated promotion of invasion and migration
of hepatocellular carcinoma cells. Cancer Res. 67:2497–2507. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang GL, Iakova P, Wilde M, Awad S and
Timchenko NA: Liver tumors escape negative control of proliferation
via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory
activity. Genes Dev. 18:912–925. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nogueira V, Park Y, Chen CC, et al: Akt
determines replicative senescence and oxidative or oncogenic
premature senescence and sensitizes cells to oxidative apoptosis.
Cancer Cell. 14:458–470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu J, Zhou J and Xing D:
Phosphatidylinositol 3-kinase plays a vital role in regulation of
rice seed vigor via altering NADPH oxidase activity. PLoS One.
7:e338172012. View Article : Google Scholar : PubMed/NCBI
|
